Please ensure Javascript is enabled for purposes of website accessibility

Why Owens & Minor Stock Is Skyrocketing Today

By Keith Speights – Jul 21, 2020 at 11:48AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are very excited about the company's sneak peek at its second-quarter results.

What happened

Shares of Owens & Minor (OMI 2.06%) were skyrocketing 69.9% higher as of 11:36 a.m. EDT on Tuesday after rising as much as 94% earlier in the day. The huge jump came after the healthcare services company provided a preliminary second-quarter update that was much better than expected.

So what

Owens & Minor expects to report adjusted earnings per share for Q2 of between $0.18 and $0.20. The average analysts' estimate projected an adjusted net loss of $0.03 per share. In addition, the company revised its full-year outlook for adjusted earnings to a range of $1 to $1.20 per share, up from its previous guidance of adjusted earnings between $0.50 and $0.60 per share.

Healthcare professional holding gloved hand up to her face mask

Image source: Getty Images.

Why is Owens & Minor anticipating a Q2 performance that blew away Wall Street expectations? The company stated that it should "benefit from improved productivity and increased manufacturing output in response to unprecedented demand for personal protective equipment, an earlier than expected increase in elective procedures across much of the country, favorable product mix, and operating efficiencies."

All of those cited factors are great news for Owens & Minor. Perhaps the most important one, though, is the faster rebound in volumes of elective procedures. This should translate to higher sales for many products in the company's catalog.

Now what

Owens & Minor is scheduled to announce its final Q2 results on Aug. 4, 2020. The update might not be as big of a catalyst for the healthcare stock as it would have otherwise been after the company's sneak peek today. Still, with shares of Owens & Minor now up more than 160% year to date, investors aren't likely to complain. 

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.